Loading
Latest filing published 24 Mar 2026 for RenovoRx, Inc..
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Shaun Bagai is a declared insider of RenovoRx, Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 19 May 2022 to 20 March 2026, the count stands at 10 filings.
On the market, this insider has only ever bought: 10 purchases, €47k in total. The totals exclude 2 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 1 purchase and no sales.
Half of the purchases are above €5,064 and half below. Of 10 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
Most recently, on 24 March 2026, the filings show an open-market purchase in RenovoRx, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations